Aeterna Zentaris Announces Data and Safety Monitoring Board Scheduled to Complete Second Interim Analysis of the ZoptEC Phase 3 Trial in Endometrial Cancer in Early October. http://finance.yahoo.com/news/aeterna-zentaris-announces-data-safety-113000737.html http://finance.yahoo.com/news/aeterna-zentaris-announces-data-safety-113000737.html